-
1 Comment
Innovative Pharmaceutical Biotech Limited is currently in a long term downtrend where the price is trading 18.9% below its 200 day moving average.
From a valuation standpoint, the stock is 71.5% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 32.2.
Innovative Pharmaceutical Biotech Limited's total revenue sank by 0.0% to $6M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-55M since the same quarter in the previous year.
Finally, its free cash flow grew by 30.4% to $-5M since the same quarter in the previous year.
Based on the above factors, Innovative Pharmaceutical Biotech Limited gets an overall score of 2/5.
| ISIN | None |
|---|---|
| Industry | |
| Sector | |
| CurrencyCode | EUR |
| Exchange | F |
| Dividend Yield | 0.0% |
|---|---|
| Beta | 0.11 |
| Target Price | None |
| PE Ratio | None |
| Market Cap | 34M |
Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products and Research and Development. It is also involved in the funds/securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FRHN.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
